GlassScriptPhysician profile
David K Swain
NPI 1528228913
$2,328.79
in general payments reported to CMS, 2019-2025
28 companies · $609 in 2025
The $609 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2020: $21.71 · 2021: $83.63 · 2022: $463 · 2023: $635 · 2024: $412 · 2025: $609.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,657.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,656.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $471.03 | 2020-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $257.07 | 2019-2025 | Collagenase Santyl, Renasys Go V2 Home, Regranex |
| Kerecis Limited | $244.07 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Access Pro Medical, LLC | $213.65 | 2023 | Matriderm |
| Organogenesis INC. | $171.82 | 2022-2025 | Affinity |
| Biocomposites INC | $126.61 | 2019-2022 | |
| Aroa Biosurgery Incorporated | $107.23 | 2023-2025 | |
| Sanara Medtech INC. | $100.71 | 2022-2025 | Celleraterx |
| Omeza LLC | $80.88 | 2024 | |
| Innovation Technologies INC | $74.17 | 2024-2025 | Irrisept |
| Solventum Corporation | $65.08 | 2024-2025 | Activ.A.C., V.A.C. Veraflo, V.A.C.Ulta |
| Next Science LLC | $60.95 | 2023 | Surgx, Xperience, Blastx |
| Globus Medical, INC. | $45.30 | 2025 | Senza |
| Urgo Medical North America, LLC | $40.31 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Cvrx, INC. | $35.80 | 2025 | Barostim Neo System |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $32.36 | 2024 | Tyvaso |
| Musculoskeletal Transplant Foundation INC. | $21.44 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $21.12 | 2024 | Arcalyst |
| Wright Medical Technology, INC. | $19.68 | 2019 | |
| Cashflow Solutions, LLC | $18.85 | 2024 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Gilead Sciences, INC. | $18.53 | 2021 | |
| Nabriva Therapeutics, Plc | $18.48 | 2022 | |
| Mimedx Group, INC. | $17.19 | 2025 | |
| Acell, INC. | $14.75 | 2019 | |
| Allergan, INC. | $13.65 | 2019 | |
| Medtronic, INC. | $13.60 | 2025 | Turbohawk |
| Cardiovascular Systems INC. | $12.70 | 2019 | |
| Abbvie INC. | $11.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Swain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.